cGxP.wire https://validator.w3.org/feed/docs/rss2.html Belay Diagnostics Reports Strong Clinical Utility for Summit 2.0 Cosmetic Physician Partners Returns $35 Million to Employee Owners Nona Biosciences and MedUni Vienna Collaborate on Infectious Diseases Nuvectis Pharma Announces China Approval of Ciprocopan for PNH GHIT Fund Accelerates Portable Ebola Diagnostic Innovation Autonomix Medical Secures New U.S. Patent for Precision Neuromodulation Platform Verastem Oncology Doses First Patient in Phase 2 VS-7375 NSCLC Trial Penumbra THUNDERBOLT Shows Strong Stroke Trial Results Pfizer Inc. Wins FDA Priority Review for Prostate Cancer Therapy Xodus Medical Study Validates Hot Pink Pad Performance Dexcom Selected as First Participant in FDA TEMPO Pilot Program GSK Wins FDA Approval for Jideytro in ROS1+ Lung Cancer Ibex Medical Analytics Strengthens Breast Cancer AI with CE-IVDR Approval Ribo Unveils Positive Phase 2a Data for Vortosiran in CAD Ascletis Reports Superior ASC36_35 Weight Loss Data at EASD 2026 BeOne Medicines Scales Cancer Drug Production in the U.S. Lakewood-Amedex Highlights Nu-3 Against Antibiotic Resistance Azafaros Finishes Patient Enrollment in NAVIGATE Phase 3 Trial LB Pharmaceuticals Accelerates Phase 3 LB-102 Schizophrenia Timeline Artelo Biosciences Advances ART12.11 Following CBD Research Review Co-Diagnostics Targets India TB Diagnostics with PCR Pro Studies BridgeBio Announces FDA Acceptance of Encaleret NDA for ADH1 Oncotelic Publishes Deciparticle Data Supporting Sapu003 Clinical Trial Serenity Medical Reports Long-Term River Stent Success in IIH Revolution Medicines FDA Accepts Daraxonrasib NDA for Pancreatic Cancer NMD Pharma Identifies New Cause of Age-Related Muscle Weakness IMNN-001 Demonstrates Clinical Promise in Advanced Ovarian Cancer Gilead Sciences and Merck & Co. Deliver Positive ISLEND Phase 3 Results Myriad Launches FirstGene for Earlier Prenatal Genetic Screening Merakris Therapeutics Wins NIH Funding for MTX-001 Alpha Tau Medical Ltd. Reports Positive Head and Neck Cancer Results Intelligent Bio Solutions Completes FDA 510(k) Precision Testing Milestone Natera Reports Signatera Superior to AMERK in MCC Monitoring Arrowhead Pharmaceuticals Reports Positive Phase 3 Plozasiran Results Johnson & Johnson FDA Clears OTTAVA Robotic Surgical System Envoy Medical Advances Acclaim Cochlear Implant Trial Seek Labs Validates ANINA Molecular Diagnostic Platform Junshi Expands Toripalimab to Stage II-III NSCLC City of Hope Launches Phase 2 Lung Cancer Biomarker Trial Pheast Therapeutics Publishes New PHST001 Oncology Research Rapid Medical Receives FDA Clearance for DRIVEWIRE 35 JCR Pharmaceuticals Wins UAE Approval for IZCARGO Estrigenix Therapeutics Secures Seed Funding to Advance ERβ Platform Ipsen Completes Memo Therapeutics Acquisition Gilead Sciences Presents New HIV Prevention and Treatment Data at AIDS 2026 Atossa Unveils (Z)-Endoxifen Data for Rare Endocrine Disease Devonian Begins Pediatric Phase II/III Thykamine Trial Seegene USA Wins FDA EUA for Multiplex PCR Assay Serina Therapeutics Completes First Cohort in SER-252 Phase 1 Trial Healx Doses First Patient in HLX-4310 Phase 1/2 Trial